Nexstim Plc (HEL:NXTMH)

Market Cap	55.02M
Revenue (ttm)	10.21M
Net Income (ttm)	-892.29K
Shares Out	7.18M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	15.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,839
Average Volume	5,702
Open	7.74
Previous Close	7.62
Day's Range	7.58 - 7.78
52-Week Range	2.66 - 10.35
Beta	0.29
RSI	46.15
Earnings Date	Aug 15, 2025

About Nexstim

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NB...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 40
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NXTMH

Financial Performance

In 2024, Nexstim's revenue was 10.21 million, an increase of 18.97% compared to the previous year's 8.58 million. Losses were -892,285, -32.79% less than in 2023.